ANJI PHARMACEUTICALS INC has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ROGERS ARPI, 7 HILLS INTERESTS LLC and CHILDRENS RES INSTITUTE CHILDRENS NATIONAL MEDICAL CENTER.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Peru | 1 | |
#9 | Singapore | 1 | |
#10 | Taiwan | 1 | |
#11 | United States | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hubbard Brian K | 10 |
#2 | Serrano-Wu Michael H | 9 |
#3 | Michael H Serrano-Wu | 1 |
#4 | Serrano Wu Michael H | 1 |
#5 | Brian K Hubbard | 1 |
Publication | Filing date | Title |
---|---|---|
AU2019234956A1 | Compositions and methods for treating severe constipation |